Indegene, 544172, INDGN Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

12,929.12
28.89
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

12,439.32
0.37%
4.49

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

23.51
24.06
7.18

EBITDA CAGR (%)

10 Years
5 Years
3 Years

26.12
18.31
6.18

PAT CAGR (%)

10 Years
5 Years
3 Years

27.64
16.98
15.19

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

EV:EBITDA (Average)

8 Years
5 Years
3 Years

Earnings Forecasts:

(Updated: 01-11-2025)

Description 2024 2025 2026 2027
Adj EPS 17.15 19.56 22.78 26.4
P/E Ratio 31.43 27.56 23.66 20.42
Revenue 2839.3 3223.4 3685.16 4130.81
EBITDA 534.3 635.37 730.84 819.43
Net Income 406.7 471.91 548.55 635.57
ROA 13.85 14.46 15.61 16.63
P/B Ratio 4.94 4.25 3.68 3.14
ROE 20.11 16.75 16.82 16.76
FCFF 338.9 473.62 466.27 625.17
FCFF Yield 2.88 4.03 3.97 5.32
Net Debt -1562.7 -1143.72 -1558.65 -2118.95
BVPS 109.15 126.77 146.61 171.93

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 306.70 281.70 8.87% 255.60 258.60 -1.16% 266.70 272.50 -2.13% 286.70 260.00 10.27%
Expenses 236.10 235.30 0.34% 218.90 219.10 -0.09% 227.10 226.10 0.44% 234.80 223.00 5.29%
EBITDA 70.60 46.40 52.16% 36.70 39.50 -7.09% 39.60 46.40 -14.66% 51.90 37.00 40.27%
EBIDTM 23.02% 16.47% 14.36% 15.27% 14.85% 17.03% 18.10% 14.23%
Other Income 17.50 22.40 -21.88% 32.10 13.70 134.31% 35.20 23.10 52.38% 22.30 12.00 85.83%
Interest 2.00 1.60 25.00% 1.70 1.50 13.33% 1.50 1.50 0.00% 1.60 1.70 -5.88%
Depreciation 8.60 6.20 38.71% 7.30 6.60 10.61% 6.90 7.60 -9.21% 6.50 6.50 0.00%
PBT 77.50 61.00 27.05% 59.80 45.10 32.59% 66.40 60.40 9.93% 66.10 40.80 62.01%
Tax 17.60 16.20 8.64% 14.70 12.50 17.60% 12.20 11.50 6.09% 16.20 11.20 44.64%
PAT 59.90 44.80 33.71% 45.10 32.60 38.34% 54.20 48.90 10.84% 49.90 29.60 68.58%
PATM 19.53% 15.90% 17.64% 12.61% 20.32% 17.95% 17.41% 11.38%
EPS 2.49 1.87 33.16% 1.88 1.36 38.24% 2.26 2.04 10.78% 2.08 1.23 69.11%

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 804.20 686.80 17.09% 760.80 676.50 12.46% 755.60 673.00 12.27% 720.40 673.40 6.98%
Expenses 663.60 560.70 18.35% 605.50 547.60 10.57% 608.10 534.30 13.81% 588.60 524.50 12.22%
EBITDA 140.60 126.10 11.50% 155.30 128.90 20.48% 147.50 138.70 6.34% 131.80 148.90 -11.48%
EBIDTM 17.48% 18.36% 20.41% 19.05% 19.52% 20.61% 18.30% 22.11%
Other Income 19.70 21.40 -7.94% 22.10 22.50 -1.78% 25.60 23.20 10.34% 37.70 13.10 187.79%
Interest 3.80 4.00 -5.00% 3.70 11.70 -68.38% 3.10 12.30 -74.80% 3.20 12.10 -73.55%
Depreciation 23.40 19.40 20.62% 21.60 20.10 7.46% 20.70 18.50 11.89% 20.00 17.60 13.64%
PBT 133.10 124.10 7.25% 152.10 119.60 27.17% 149.30 133.50 11.84% 146.30 132.30 10.58%
Tax 31.00 32.40 -4.32% 35.70 31.90 11.91% 31.70 38.70 -18.09% 36.60 33.50 9.25%
PAT 102.10 91.70 11.34% 116.40 87.70 32.73% 117.60 94.80 24.05% 109.70 98.80 11.03%
PATM 12.70% 13.35% 15.30% 12.96% 15.56% 14.09% 15.23% 14.67%
EPS 4.25 3.84 10.68% 4.86 3.66 32.79% 4.91 4.27 14.99% 4.59 4.45 3.15%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 1,115.70 1,093.60 1,045.60 1,005.70 836.70 511.00 192.28 154.00 109.00 89.22 83.13 Net Sales Growth 4.00% 4.59% 3.97% 20.20% 63.74% 165.76% 24.86% 41.28% 22.17% 7.33% Cost Of Goods Sold 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Gross Profit 1,115.70 1,093.60 1,045.60 1,005.70 836.70 511.00 192.28 154.00 109.00 89.22 83.13 GP Margin 100.00% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% Total Expenditure 916.90 913.10 877.60 828.10 668.00 361.00 159.58 130.68 99.46 79.82 68.78 Power & Fuel Cost - 0.00 0.00 0.00 1.10 1.00 1.26 0.96 1.03 0.00 0.00 % Of Sales - 0% 0% 0% 0.13% 0.20% 0.66% 0.62% 0.94% 0% 0% Employee Cost - 759.20 752.30 701.20 526.00 273.00 108.14 83.64 63.37 0.00 0.00 % Of Sales - 69.42% 71.95% 69.72% 62.87% 53.42% 56.24% 54.31% 58.14% 0% 0% Manufacturing Exp. - 32.90 23.50 36.40 76.20 49.50 15.40 16.72 12.15 0.00 0.00 % Of Sales - 3.01% 2.25% 3.62% 9.11% 9.69% 8.01% 10.86% 11.15% 0% 0% General & Admin Exp. - 112.40 93.30 81.40 58.90 31.40 30.35 27.46 22.74 79.82 68.78 % Of Sales - 10.28% 8.92% 8.09% 7.04% 6.14% 15.78% 17.83% 20.86% 89.46% 82.74% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0.04% 0% 0% Miscellaneous Exp. - 8.60 8.50 9.10 5.80 6.10 4.43 1.90 0.14 0.00 0.00 % Of Sales - 0.79% 0.81% 0.90% 0.69% 1.19% 2.30% 1.23% 0.13% 0% 0% EBITDA 198.80 180.50 168.00 177.60 168.70 150.00 32.70 23.32 9.54 9.40 14.35 EBITDA Margin 17.82% 16.51% 16.07% 17.66% 20.16% 29.35% 17.01% 15.14% 8.75% 10.54% 17.26% Other Income 107.10 90.40 50.30 37.10 27.80 24.50 3.11 8.28 7.50 4.60 0.00 Interest 6.80 6.20 6.60 6.40 3.00 3.50 1.42 0.51 0.63 0.66 2.14 Depreciation 29.30 26.20 31.10 31.70 23.60 17.60 3.56 3.23 2.62 3.06 2.32 PBT 269.80 238.50 180.60 176.60 169.90 153.40 30.82 27.85 13.79 10.28 9.90 Tax 60.70 57.20 42.70 46.40 37.20 26.90 1.24 -0.65 2.29 2.61 3.30 Tax Rate 22.50% 23.98% 23.64% 26.27% 21.90% 17.20% 4.02% -2.33% 16.61% 25.39% 33.33% PAT 209.10 181.30 137.90 130.20 132.70 129.50 29.58 28.50 11.50 7.67 6.60 PAT before Minority Interest 209.10 181.30 137.90 130.20 132.70 129.50 29.58 28.50 11.50 7.67 6.60 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 18.74% 16.58% 13.19% 12.95% 15.86% 25.34% 15.38% 18.51% 10.55% 8.60% 7.94% PAT Growth 34.12% 31.47% 5.91% -1.88% 2.47% 337.80% 3.79% 147.83% 49.93% 16.21% EPS 8.71 7.55 5.74 5.42 5.53 5.39 1.23 1.19 0.48 0.32 0.27

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 17 Mar 16 Mar 15
Net Sales 3,041.00 2,839.30 2,589.60 2,306.10 1,664.61 966.27 472.06 343.75 233.52 Net Sales Growth 12.23% 9.64% 12.29% 38.54% 72.27% 104.69% 37.33% 47.20% Cost Of Goods Sold 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Gross Profit 3,041.00 2,839.30 2,589.60 2,306.10 1,664.61 966.27 472.06 343.75 233.52 GP Margin 100.00% 100% 100% 100% 100% 100% 100% 100% 100% Total Expenditure 2,465.80 2,305.00 2,084.20 1,910.20 1,377.69 735.74 401.24 291.26 203.85 Power & Fuel Cost - 0.00 0.00 0.00 0.00 0.00 1.51 1.00 1.09 % Of Sales - 0% 0% 0% 0% 0% 0.32% 0.29% 0.47% Employee Cost - 1,815.20 1,651.60 1,464.80 1,014.34 535.60 265.21 183.32 103.55 % Of Sales - 63.93% 63.78% 63.52% 60.94% 55.43% 56.18% 53.33% 44.34% Manufacturing Exp. - 171.80 168.10 200.60 214.41 119.40 45.53 43.22 54.63 % Of Sales - 6.05% 6.49% 8.70% 12.88% 12.36% 9.64% 12.57% 23.39% General & Admin Exp. - 271.90 242.80 223.50 137.04 74.79 85.37 58.76 43.07 % Of Sales - 9.58% 9.38% 9.69% 8.23% 7.74% 18.08% 17.09% 18.44% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.09 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0.47% Miscellaneous Exp. - 46.10 21.70 21.30 11.89 5.96 3.62 4.97 0.42 % Of Sales - 1.62% 0.84% 0.92% 0.71% 0.62% 0.77% 1.45% 0.18% EBITDA 575.20 534.30 505.40 395.90 286.92 230.53 70.82 52.49 29.67 EBITDA Margin 18.91% 18.82% 19.52% 17.17% 17.24% 23.86% 15.00% 15.27% 12.71% Other Income 105.10 107.20 76.30 58.20 25.89 30.65 0.24 3.50 3.97 Interest 13.80 22.00 49.40 31.30 5.96 6.96 9.66 2.46 2.37 Depreciation 85.70 80.20 76.10 59.80 33.45 25.55 19.12 15.19 7.46 PBT 580.80 539.30 456.20 363.00 273.39 228.67 42.28 38.34 23.81 Tax 135.00 132.60 121.90 96.90 63.68 45.78 3.20 2.91 5.48 Tax Rate 23.24% 24.59% 26.58% 26.69% 28.12% 19.76% 7.57% 7.59% 23.02% PAT 445.80 406.70 336.70 266.10 164.76 185.67 39.08 35.43 18.33 PAT before Minority Interest 445.80 406.70 336.70 266.10 162.82 185.68 39.08 35.43 18.33 Minority Interest 0.00 0.00 0.00 0.00 1.94 -0.01 0.00 0.00 0.00 PAT Margin 14.66% 14.32% 13.00% 11.54% 9.90% 19.22% 8.28% 10.31% 7.85% PAT Growth 19.52% 20.79% 26.53% 61.51% -11.26% 375.10% 10.30% 93.29% EPS 18.57 16.94 14.02 11.08 6.86 7.73 1.63 1.48 0.76

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 1,888.20 953.80 795.30 650.00 253.90 118.49 110.76 97.33 90.29 85.89 Share Capital 47.90 44.40 44.30 0.40 0.30 78.87 72.00 72.00 72.00 64.57 Total Reserves 1,804.10 878.00 733.20 643.80 249.20 38.85 31.18 24.39 18.29 13.89 Non-Current Liabilities 50.40 53.20 59.40 48.80 7.10 2.21 2.16 1.58 0.00 1.62 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.58 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 Long Term Provisions 58.50 43.20 35.00 26.50 13.20 2.62 2.36 1.74 0.00 0.00 Current Liabilities 189.50 198.10 169.40 140.70 93.30 42.12 30.28 18.78 14.01 9.76 Trade Payables 34.80 57.30 24.50 25.80 42.80 7.96 5.47 4.20 0.55 0.93 Other Current Liabilities 106.70 96.80 104.70 91.50 33.30 13.56 12.78 10.77 10.52 7.10 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 12.34 4.81 0.00 0.00 0.00 Short Term Provisions 48.00 44.00 40.20 23.40 17.20 8.26 7.21 3.82 2.94 1.73 Total Liabilities 2,128.10 1,205.10 1,024.10 839.50 354.30 162.82 143.20 117.69 104.30 97.27 Net Block 52.80 56.10 78.30 72.00 40.60 8.44 9.72 2.68 2.47 2.22 Gross Block 183.20 175.20 187.40 149.40 99.40 18.99 17.21 7.85 6.37 5.05 Accumulated Depreciation 130.40 119.10 109.10 77.40 58.80 10.55 7.49 5.17 3.90 2.83 Non Current Assets 910.10 454.10 321.20 305.00 136.40 129.60 101.57 80.82 62.25 57.74 Capital Work in Progress 3.60 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 471.30 385.40 231.50 83.40 83.40 77.02 62.21 59.98 59.78 55.52 Long Term Loans & Adv. 382.00 12.50 11.10 149.50 12.30 36.44 23.58 13.81 0.00 0.00 Other Non Current Assets 0.40 0.10 0.30 0.10 0.10 7.71 6.07 4.35 0.00 0.00 Current Assets 1,218.00 751.00 702.90 534.50 217.90 33.22 41.63 36.87 42.05 39.53 Current Investments 503.30 238.40 168.80 119.90 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Sundry Debtors 418.40 378.00 400.80 349.50 175.10 15.76 26.21 18.35 21.20 15.81 Cash & Bank 163.60 15.60 54.00 38.80 18.20 4.21 2.70 6.23 3.78 5.31 Other Current Assets 132.70 100.40 62.00 24.30 24.60 13.26 12.73 12.28 17.07 18.41 Short Term Loans & Adv. 70.80 18.60 17.30 2.00 3.10 10.51 0.92 0.91 16.25 17.99 Net Current Assets 1,028.50 552.90 533.50 393.80 124.60 -8.90 11.35 18.09 28.04 29.76 Total Assets 2,128.10 1,205.10 1,024.10 839.50 354.30 162.82 143.20 117.69 104.30 97.27

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Shareholder's Funds 2,615.60 1,429.10 1,063.80 763.90 324.51 Share Capital 47.90 44.40 44.30 0.35 0.31 Total Reserves 2,531.60 1,353.30 1,001.70 757.79 319.79 Non-Current Liabilities 56.00 434.80 583.90 79.97 26.79 Secured Loans 0.00 333.40 394.30 10.94 17.69 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 58.50 43.20 35.00 26.47 12.30 Current Liabilities 564.50 610.90 489.10 440.44 199.43 Trade Payables 93.40 118.10 73.30 74.22 50.19 Other Current Liabilities 395.30 402.50 354.30 305.48 128.39 Short Term Borrowings 0.00 9.70 0.00 0.00 0.00 Short Term Provisions 75.80 80.60 61.50 60.74 20.84 Total Liabilities 3,236.10 2,474.80 2,136.80 1,284.31 559.30 Net Block 677.60 645.80 664.10 137.72 85.92 Gross Block 1,095.50 995.10 863.40 271.29 191.10 Accumulated Depreciation 417.90 349.30 199.30 133.56 105.19 Non Current Assets 706.10 684.00 688.10 154.29 100.01 Capital Work in Progress 3.60 0.00 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 22.40 35.00 20.30 16.48 14.03 Other Non Current Assets 2.50 3.20 3.70 0.08 0.06 Current Assets 2,530.00 1,790.80 1,448.70 1,130.03 459.29 Current Investments 1,289.70 796.50 614.00 119.86 0.00 Inventories 0.00 0.00 0.00 0.00 0.00 Sundry Debtors 751.40 648.00 642.00 443.91 285.40 Cash & Bank 374.60 191.00 85.80 517.30 139.90 Other Current Assets 114.30 121.40 70.70 42.49 33.99 Short Term Loans & Adv. 60.10 33.90 36.20 6.46 0.65 Net Current Assets 1,965.50 1,179.90 959.60 689.59 259.87 Total Assets 3,236.10 2,474.80 2,136.80 1,284.32 559.30

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 14
Cash From Operating Activity 129.00 176.20 81.90 38.20 53.30 23.83 PBT 238.50 180.60 176.60 169.90 159.90 10.28 Adjustment -40.30 2.50 32.80 15.50 11.30 3.12 Changes in Working Capital 1.40 42.40 -85.70 -111.30 -92.30 13.25 Cash after chg. in Working capital 199.60 225.50 123.70 74.10 78.90 26.65 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -70.60 -49.30 -41.80 -35.90 -25.60 -2.81 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -824.70 -187.70 -47.90 -266.70 -33.20 -29.85 Net Fixed Assets -11.60 12.20 -38.00 -50.00 -80.41 Net Investments -350.80 -223.50 -197.00 -119.90 -6.38 Others -462.30 23.60 187.10 -96.80 53.59 Cash from Financing Activity 717.30 -15.80 -16.90 244.90 -37.10 7.52 Net Cash Inflow / Outflow 21.60 -27.30 17.10 16.40 -17.00 1.51 Opening Cash & Equivalents 13.20 41.80 27.80 11.60 29.50 2.70 Closing Cash & Equivalent 35.20 13.20 41.80 27.80 11.60 4.21

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Cash From Operating Activity 441.90 507.70 130.20 297.04 172.03 PBT 539.30 458.60 363.00 226.50 195.85 Adjustment 38.50 78.20 91.40 87.07 17.29 Changes in Working Capital 24.10 95.80 -216.00 53.82 8.51 Cash after chg. in Working capital 601.90 632.60 238.40 367.39 221.64 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -160.00 -124.90 -108.20 -70.35 -49.61 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -682.70 -327.20 -893.30 -160.21 -24.25 Net Fixed Assets -11.60 12.20 -38.00 -50.00 Net Investments -350.80 -223.50 -197.00 -119.90 Others -320.30 -115.90 -658.30 9.69 Cash from Financing Activity 287.50 -66.20 333.10 233.48 -131.51 Net Cash Inflow / Outflow 46.70 114.30 -430.00 370.31 16.28 Opening Cash & Equivalents 188.60 73.60 506.30 133.36 173.86 Closing Cash & Equivalent 241.00 188.60 73.60 506.28 133.36

Financial Ratios

Standalone /

Consolidated

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 77.33 41.55 35.10 25.56 13.20 254.06 204.28 166.35 120.78 92.19 ROA 10.88% 12.37% 13.97% 22.23% 33.71% 5.01% 5.06% 5.49% 4.37% 4.02% ROE 13.07% 16.22% 18.32% 29.70% 107.25% 21.51% 23.50% 28.16% 26.85% 30.46% ROCE 17.22% 21.41% 25.32% 38.26% 54.43% 8.88% 11.31% 8.43% 6.45% 5.08% Fixed Asset Turnover 6.10 5.77 5.97 6.73 7.27 4.93 6.63 8.48 7.03 7.47 Receivable days 132.90 135.93 136.15 114.43 83.86 85.84 97.82 119.63 168.37 170.55 Inventory Days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Payable days 0.00 0.00 0.00 0.00 0.00 802.29 760.90 680.30 168.77 219.24 Cash Conversion Cycle 132.90 135.93 136.15 114.43 83.86 -716.45 -663.08 -560.66 -0.40 -48.69 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.10 0.05 0.00 0.00 0.02 Interest Cover 39.47 28.36 28.59 57.63 45.69 16.66 5.64 7.18 19.86 39.54

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Book Value (Rs.) 107.70 62.96 47.22 34.28 16.23 ROA 14.24% 14.60% 15.56% 17.66% 33.13% ROE 20.45% 27.56% 29.50% 30.20% 176.32% ROCE 25.24% 30.88% 35.20% 41.09% 68.54% Fixed Asset Turnover 2.72 2.79 4.06 7.20 4.71 Receivable days 89.95 90.91 85.94 79.96 87.03 Inventory Days 0.00 0.00 0.00 0.00 0.00 Payable days 0.00 0.00 0.00 0.00 0.00 Cash Conversion Cycle 89.95 90.91 85.94 79.96 87.03 Total Debt/Equity 0.00 0.29 0.38 0.02 0.08 Interest Cover 25.51 10.28 12.60 38.98 34.27

Top Investors:

nadathur fareast pte ltd

manish gupta

rajesh bhaskaran nair

bpc genesis fund i spv ltd

sanjay s parikh

bpc genesis fund i a spv ltd

smallcap world fund, inc

gaurav kapoor

vida trustees private limited

llp

Annual Reports:

News Update:

Indegene reports 11% rise in Q2 consolidated net profit
31st Oct 2025, 14:50 PM

The consolidated total income of the company increased by 16.34% at Rs 823.90 crore for Q2FY26
Read More
Indegene gets nod to invest in equity shares of Indegene Ireland
31st Oct 2025, 12:00 PM

This investment in Indegene Ireland is to support the Subsidiary with capex requirement intended to expand its business
Read More
Indegene’s arm inks pact to acquire 100% stake in Warn and Co
17th Oct 2025, 14:40 PM

The objective of acquisition is to further augment Indegene's capabilities and offerings in life sciences consulting business
Read More
Indegene, Datavant partner to enhance clinical trial recruitment
20th Sep 2025, 12:39 PM

Combined with Indegene’s suite of digitally powered solutions for clinical trial recruitment, the partnership streamlines the identification of suitable participants for studies based on specific health data criteria
Read More
Indegene expands India footprint
5th Sep 2025, 15:18 PM

The company has opened a new center in Pune
Read More
Indegene - Quarterly Results
31st Jul 2025, 17:44 PM

Read More

Indegene Ltd.

Business Support

BSE: 544172 | NSE: INDGN

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

Indegene Ltd.

Business Support

BSE: 544172 | NSE: INDGN

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: